Abstract. Tumorigenicity of mouse melanoma cells is reduced or lost upon growth in vitro in 1 to 3 jg/ml of 5-bromodeoxyuridine (BUdR). The rate of growth is very little affected by these concentrations. The morphology of the cells is altered, such that the cells grow in a flattened, often fibroblastic monolayer, showing contact inhibition, instead of the rounded, multilayered mounds characteristic of the line. Melanotic cells lose their pigment-producing ability within one week. These effects are reversible and the inclusion of thymidine with BUdR prevents their occurrence. The reduction in tumorigenicity, the effects on cell morphology, and the suppression of pigmentation occur in clones derived from single cells growing in BUdR as well as in mass populations. These clones appear capable of indefinite growth in vitro in BUdR with altered morphology. The suppression of cytodifferentiation in these melanoma cells and in embryonic cells, coupled with the modification of malignancy, leads to the hypothesis that both differentiation and malignancy are regulated by similar cellular mechanisms. These effects of BUdR offer promise of a powerful tool to probe these regulatory mechanisms.
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Cytodifferentiation in a variety of embryonic tissues is reversibly suppressed by low concentrations of 5-bromodeoxyuridine BUdR. 1I7 Pigmentation is among the differentiated functions suppressed, both in embryonic retinal and in iris epithelium (Fig. 3A) . It was of interest to see whether similar effects would be obtainable in a mouse melanoma line that has been induced to grow in vitro with virtually every cell pigmented.8 In addition, since malignancy can be viewed as an aberrant form of differentiation, it also seemed worthwhile to test the tumorigenicity of BUdR-treated cells.
Materials and Methods. The cell lines used were derived from a B16 mouse melanoma, and clonal derivatives were maintained in a fully pigmented state as described previously.8 The amelanotic clone from which these lines were derived was also used. Methods of cell culture, cloning, and medium (Eagle's minimal medium with 10% fetal calf serum) used were the same as previously described.8 BUdR (Nutritional Biochemicals, Cleveland, Ohio) was added to the medium at the final concentrations described.
Incorporation of 8H-BUdR (0.5,uCi/ml, 11 Ci/m mole, New England Nuclear Corp., Boston, Mass.) was followed by autoradiography by using the procedures already described.8 Cells on cover slips were grown in radioactive medium for 1, 5, and 24 hr. Some cover slips were immediately washed, fixed, and processed, others were For quantitative determination of incorporated radioactivity, cover slips containing cells grown in 3H-BUdR for 1, 5, and 24 hr were washed as described, extracted twice with ice-cold 5% trichloroacetic acid, washed with ethanol: ether (3: 1) and then with ether, and dried. They were placed in scintillation vials with 0.5 ml concentrated formic acid and scintillation fluid, and the radioactivity was determined with a Packard Tri-Carb liquid scintillation counter.
Protein was determined in replicate flasks at the time points shown in Figure 2 by the Oyama and Eagle9 modification of the Lowry method. Melanin was extracted three times with ice-cold 5% trichloroacetic acid, twice with ethanol: ether (3:1), once with ether, and dried. The extract was dissolved in hot 0.85 N KOH, cooled, and the absorbance read at 420 mjA in a Beckman DU spectrophotometer.
Tumorigenicity was tested by injection of 106 viable cells (as determined by trypan blue exclusion) into 6-week-old C57BL/6J mice.
Results. Within the first week of treatment with BUdR (1-3 ,ug/ml), there is little or no effect on the growth of the cells (Figs. 1 and 2) but there is a marked effect on pigment production and cell morphology (Figs. 2-4). The cells grow without pigment and are flattened and largely contact-inhibited. This is in sharp contrast with the highly melanotic cells which pile up to form the dark mounds characteristic of the clonally derived melanoma line. The BUdR effects are reversible on growth in normal medium after up to 100 days on BUdRcontaining medium (Figs. 5C, D, G-I). The effects can be prevented by the addition of equimolar quantities of thymidine ( Fig. 30 ), but reversibility is not improved by the addition of thymidine to normal medium.
As these cells continue to grow in BUdR-containing medium, they often form somewhat enlarged and vacuoles are common, both in the early and later stages. These are more prevalent in cells grown in 3 gg/ml of BUdR than in the lower concentrations (Figs. 5E, F) . The growth rate decreases somewhat, but subculture is required as frequently as with the untreated cells-about once a week.
Since there is contact inhibition of growth, the cells do not pile up and slough off the surface of the container, as do untreated cells if they are allowed to grow without subculture beyond a week or 10 days. These cells seem capable of growing indefinitely in these low concentrations of BUdR. One line was maintained for 9 months in BUdR (1 jhg/ml) before being frozen in liquid nitrogen. Viability of the lines ranged from 67 to 90%.
Clones derived from single cells isolated in each of these concentrations of BUdR grew like the mass populations described. The tumorigenicity of clones isolated in medium containing 1-2 .ug BUdR/ml is much reduced from that of the original cell line, and tumorigenicity is completely abolished in the clones isolated in medium containing 3 Ag BUdR/ml (Table 1, Fig. 6 ).
To test the required length of pretreatment with 3 ug/ml of BUdR before modification of tumorigenicity occurred, melanoma cells were grown in BUdRcontaining medium (3 jsg/ml) for 0 to 31 days in vitro before injection into C57BL mice. The results of such treatment for 0 to 7 days is given in Figure 7 . Cells pretreated for 11 to 31 days formed one tumor in a total of 24 mice tested. All mice were kept under observation for at least 70 days after injection. 
